FIELD: medicine.
SUBSTANCE: method of obtaining live cultural attenuated vaccine for the prevention of varicella includes infection with varicella-zoster virus strain of OKA diploid cells LEC-3 with the subsequent reproduction and the release of virus into cultural medium. Thereafter, at least one collection of the virus-containing liquid, the addition of a stabiliser and the preparation of the vaccine are carried out. The group of inventions also relates to the use of a strain of diploid LEC-3 cells for the production of a live cultural attenuated vaccine for the prevention of varicella. The use of diploid cells of strain LEC-3 with high adhesiveness to the surface of growth allows to obtain from 7 to 15 individual virus collections with a high content of extracellular vaccine Varicella zoster virus.
EFFECT: obtaining extracellular virus Varicella zoster by individual collections from infected diploid cells LEC-3 using trisodium citrate provides increased harvest of Varicella zoster virus than in similar cultural models when used as a dispersant of trypsin.
7 cl, 1 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
STRAIN "vFIRAVAX" FOR PRODUCING AN ATTENUATED ALIVE CULTURE VACCINE FOR PREVENTING VARICELLA | 2019 |
|
RU2693440C1 |
VIRAL STRAIN FOR OBTAINING ATTENUATED LIVE CULTURE VACCINE FOR PREVENTION AND TREATMENT OF HERPES ZOSTER FOR ADULT POPULATION | 2020 |
|
RU2750818C1 |
METHOD OF PRODUCING FOUR-COMPONENT LIVE CULTURE VACCINE AGAINST MEASLES, VARICELLA, MUMPS, AND RUBELLA | 2019 |
|
RU2717769C1 |
METHOD OF VACCINE PREPARING, A METHOD OF CELL-FREE VACCINE PREPARING, A METHOD OF CELLS CULTURING, A NUTRIENT MEDIUM | 1993 |
|
RU2126269C1 |
STRAIN OF HUMAN EMBRYO LUNG FIBROBLAST DIPLOID CELLS USED FOR VIRUS CULTURING | 1997 |
|
RU2146289C1 |
NEW VARICELLA ZOSTER VIRUS STRAINS AND VARICELLA AND HERPES ZOSTER VACCINE USING THESE STRAINS | 2012 |
|
RU2580003C2 |
METHOD FOR CULTIVATION OF FETAL PORCINE CELLS FOR VIROLOGY | 2021 |
|
RU2795135C2 |
VACCINE STRAIN OF MEASLES VIRUS "ORLOV-D" AND METHOD OF PREPARING VACCINE AGAINST MEASLES | 1999 |
|
RU2173344C2 |
HUMAN IMMUNODEFICIENCY VIRUS STRAIN TYPE 1 IV741 SUBTYPE AE FOR DIAGNOSTIC AND VACCINE PREPARATIONS | 2012 |
|
RU2520814C2 |
RECOMBINANT VACCINE AGAINST VARICELLA ZOSTER VIRUS (VZV) | 2020 |
|
RU2772902C1 |
Authors
Dates
2017-11-29—Published
2016-12-20—Filed